04:08 PM EST, 11/18/2024 (MT Newswires) -- Christopher Mutz, Head of Rare Disease, on November 15, 2024, sold 6,500 shares in Ani Pharmaceuticals ( ANIP ) for $375,050. Following the Form 4 filing with the SEC, Mutz has control over a total of 76,777 shares of the company, with 76,777 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1023024/000184648724000014/xslF345X05/wk-form4_1731963799.xml